Early Life and Education
Felix Baker was born in March 1969. He graduated from Stanford University with a B.S. in Biology and a Ph.D. in Immunology, having also completed two years of medical school. His academic background provided a solid foundation for his career in biotechnology.
Rise to Success
Baker's career in finance began in 1994, with a biotechnology investment partnership with the Tisch family. In 2000, he co-founded Baker Bros. Advisors with his brother, Julian Baker. The firm is a New York-based hedge fund specializing in biotechnology investments. The firm's success is reflected in its management of over $18 billion in assets as of March 2025. Baker's firm has been noted for its strong returns, with an estimated $8 billion gain from an early investment in Seagen.
Key Business Strategies
Baker Bros. Advisors focuses on long-term value creation within the biotech sector through a research-driven strategy, often backing early-stage companies. The firm's approach includes deep scientific due diligence and holding positions through clinical trial phases.
Philanthropy
Felix Baker serves on the advisory council that oversees the interdisciplinary biosciences institutes at Stanford, including Bio-X, the Neurosciences Institute, and ChEM-H. The firm has a reputation for a personalized approach to wealth management and for delivering solutions tailored to client needs.
